Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.13099
Abstract: Technosphere Insulin (TI) is an inhaled insulin. Studies comparing TI with shortâacting insulin analogues provide important insights on efficacy, dosing, and time course of action. read more here.
Keywords: insulin; results early; understanding inhaled; technosphere insulin ... See more keywords
Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of diabetes science and technology"
DOI: 10.1177/19322968221110622
Abstract: BACKGROUND Technosphere Insulin (TI) is an ultra-rapid-acting inhaled insulin. This study assessed the mean peak two-hour postprandial glucose concentration with the initial TI dose (dose 1) calculated per the current label (United State Prescribing Information)… read more here.
Keywords: dose; hour postprandial; peak; two hour ... See more keywords